Login

Chief Officer Q&A: Journey to Leadership | Kyung Bae Kim - Chairman of HMM Co Ltd 00:10:00

Share On Facebook Share On Twitter

Kyung Bae Kim is Chief Executive Officer at Hmm Co Ltd.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Sustainable Growth and Community Commitment at Rabobank | Stefaan Decraene, CEO, Rabobank.
00:10:00
Pioneering Virology Company Aims to Develop Functional Cure for Hepatitis B and Treatments for Coronavirus Infections | William H. Collier, CEO, Arbutus Biopharma Corp.
00:10:00
Celebrating a decade of growth and success, multi-brand franchisor anticipates continued expansion | Stephen Hemsley, CEO, Franchise Brands PLC.
00:00:00
Dr Luís Henrique Wolff Gowdak , Mayo Clinic
00:10:00
Exploring Promising Opportunities in Bolivia: Insights from Matthew at Mining Investment Cape Town
00:10:00
FDA Grants Orphan Drug Designation to Cardiol Therapeutics' Lead Candidate for Recurrent Pericarditis| David Elsley, CEO, Cardiol Therapeutics Inc.
00:10:00
Ville Simola from Digimentalisti at Lassila & Tikanoja Oyj participates in the Nordic StrategyForum Executive IT 2017.
00:10:00
Addressing the Need for Unbiased Financial Planning: Starting an Hourly-Only Firm
00:10:00
supporting, mentoring, and investing in companies and startups at all stages of growth|Bill Liao, General Partner, venture fund SOSV
00:10:00
Navigating the Economic Landscape: Insights from Ken's Discussion on Fixed Income, Fiscal Policy, and Inflation | Roberto Sallouti, CEO , BTG Pactual.
00:10:00
Alexander Geis Discusses Opportunities and Challenges in Mexico's Cargo Transport Industry | Alexander Geis, CEO , SAF-HOLLAND SE.
00:10:00
"Tom Stevenson's Top ISA and SIPP Fund Picks for 2023"

© 2026 Nehu